📊 Analyst Consensus & Targets
- Analyst Rating: Buy
- Price Target: $132.37846
- Sector: Healthcare – Drug Manufacturers – General
💡 The Growth Thesis
Buy Consensus: Gilead Sciences, Inc. Analysts project a 7.9% potential upside. Currently trading at a Forward P/E of 14.03524.